Pucci Paolo 4

What Happened

• Paolo Pucci, a director of Replimune Group, Inc. (REPL), was granted a derivative award on April 1, 2026 for 44,500 shares. The reported acquisition price is $0.00, so there was no cash paid. The filing classifies the transaction as a derivative (an option) rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-04-01 (Form 4 filed 2026-04-07).
• Instrument/amount: Grant of derivative securities (option) covering 44,500 shares at $0.00 (total reported value $0).
• Vesting: Footnote states the shares underlying this option vest in full on April 1, 2027.
• Shares owned after the transaction: Not specified in the Form 4 filing.
• Timeliness: The Form 4 was filed late due to an “inadvertent administrative error” (late filing flag).

Context

• This was an award/option grant, not a cash purchase or sale. The option’s full vesting is a year away, so there is no immediate share issuance or sale reported. Late filings are typically administrative but mean the market got delayed disclosure of the grant; the filing notes the late submission reason.